Company profile
Edesa Biotech company profile
Edesa Biotech is a clinical-stage private company focused on developing treatments for dermatological and anorectal diseases. The initial focus is on developing novel, safe and potent alternatives to steroids for Allergic Contact Dermatitis, Hemorrhoids, and Anal Fissures. Edesa Biotech’s lead asset, EB01 is a novel non-steroidal anti-inflammatory molecule for the treatment of allergic contact dermatitis which has already demonstrated statistically significant improvements in multiple clinical studies.
Business identity
- Website
- http://edesabiotech.com/
- Contact email
- [email protected]
- Phone number
- (905)-475 1234
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2015-01-01
Headquarters
- Headquarters
- Canada, Markham, Ontario
- Postal code
- L3R 5H6
- Country code
- CA
- Continent
- North America